The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 26th 2024
Increased levels of absolute lymphocyte count are associated with improved response to BCMA-targeted CAR T-cell therapy.
Attitude, Education Among Non-Economic Barriers Hinder Adoption of Biosimilars
June 28th 2024Health professionals have expressed concerns regarding consistent naming standards, the regulatory process surrounding the approval of biosimilar drugs, and the lack of education they have about biosimilars.
Read More
BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing Efficacy vs Safety
June 21st 2024The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).
Read More
Drug Shortages in Community Oncology: Ensuring Access to Chemotherapy
Persistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.
Read More
Growing Use of Herbal Medicine in Cancer Patients Highlights Risks, Communication Gaps
June 16th 2024As patients take more proactive roles in their health, they may feel too intimidated to discuss herbal medicinal use with their providers or may be unaware of potential interactions with their drug therapies.
Read More
Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia
This article provides an overview of data supporting the utility of covalent Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia and details important considerations when choosing among agents.
Read More